• Home
  • For Physicians
    • About our Assay
    • The Ordering Process
  • For BioPharma
  • Publications
  • More
    • Home
    • For Physicians
      • About our Assay
      • The Ordering Process
    • For BioPharma
    • Publications
  • Home
  • For Physicians
    • About our Assay
    • The Ordering Process
  • For BioPharma
  • Publications

A 32 Biomarker Assay for Advanced Breast Cancer

Using our novel Reverse Phase Protein Arrays (RPPA), we can measure the activation state of key drug targets and signaling pathways within a microscopic quantity of tumor sample.  By measuring the drug targets themselves in this way, we are able to go beyond genetics and genomics to aid in treatment decision making.

LIst of targets

What we offer

Ease of Ordering

Our ordering process consists of a one-page test request form to be completed by the treating physician's office, with key information required - location of the sample, treatment history, pathology report and relevant insurance information.  Once received, our team will do the rest

How to Order

Actionable Results

All 32 biomarkers on the assay are tied to FDA approved drugs,  so a result with significant findings will show which drugs are most appropriate based on the expression and activation of that target.

Sample report

Clinical Support

Our team of expert scientists and researchers bring a wealth of knowledge and experience to Ignite Proteomics.  As specialists in the field of proteomic, our team is committed to providing the extra level of support needed to better understand the role that proteomics can have in developing your treatment plan.

Contact our team

Treatment options for breast cancer continue to grow. We can help navigate your choices.

With continued excitement around the approval of antibody drug conjugates like trastuzumab deruxtecan, being able to measure the drug target itself has never been more important.   To learn how we measure key biomarkers like total HER2 and phospho-HER2, along with the 30 other key biomarkers in the breast cancer treatment pathway, please clink the link below.

Contact us

Copyright © 2024 Ignite Proteomics - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept